Our partnership in the Western Pacific Region
Evolution of the CCM partnership in the Western Pacific region, challenges faced in programming, key areas of progress and priorities for 2022-2023, and strategies to accelerate funding absorption for TB/HIV and malaria grants. Emphasis on governance, stakeholder engagement, and risk management for effective delivery on GF strategy.
Download Presentation
Please find below an Image/Link to download the presentation.
The content on the website is provided AS IS for your information and personal use only. It may not be sold, licensed, or shared on other websites without obtaining consent from the author. Download presentation by click this link. If you encounter any issues during the download, it is possible that the publisher has removed the file from their server.
E N D
Presentation Transcript
Our partnership in the Western Pacific Region 19th 26th February 2023 PIRM CCM Meeting, Fiji
2020-2022 Programming Challenges- delayed shipments Lock downs/Country Border Closure/Personal Losses Natural Disasters (Vanuatu/Tonga/Fiji) Lockdown restrictions 2
Evolution of CCM to deliver on GF strategy & Governance 01 Accelerate to absorb 100% of GC6 funding by 31/12/2023 02 MCWP Portfolio Priorities 2023 Develop high-quality Funding Requests for GC7 aligned to new GF strategy 03 Develop high-quality, implementation-ready grants by 30 November 2023 04 Cross-cutting RSSH & PPR priorities 05
Key Areas Progress/Priorities 2022-2023 Oversight Coaching Periodic oversight visits conducted Data-driven discussions (Dashboard) Feedback mechanism/loop Active oversight of investments Engagement of key stakeholders Health Development Partners Vanuatu MSC/Malaria Steering Committee Pacific Health Forum/Climate Change Coordination at the country level positioning strategy for better coordination of health programs, investments including preparedness & response Linkages with national structures Well-functioning governance Provides strategic steer for GF investment decisions Training of Civil society Reps; Ethical leadership and governance Risks Management (Top 3)/Deep-Dives plus continued follow through Evolution of CCM to deliver on GF strategy & Governance 5
2. Accelerate to absorb 100% of GC6 funding by 31/12/2023 Grant TB/HIV Grant 1-Jan-21 31-Dec-21 C From To 1-Jan-22 31-Dec-22 C/B 1-Jan-23 31-Dec-23 Programmatic Rating Financial Absorption Rate 78% 72% Grant Malaria Grant (Vanuatu) 1-Jan-21 31-Dec-21 31-Dec-22 C From To 1-Jan-22 1-Jan-23 31-Dec-23 Programmatic Rating B Financial Absorption Rate 58% 63% 6
Grant Item Timelines agreed N/A Status Key Program Priorities GC6 QUA-C- UNDP QUA-C- UNDP QUA-C- UNDP Capacity Development Plan for PSM Completed Plan for undertaking and adopting index testing N/A Completed Regional / Country specific M&E Plan 31 August 2022 In progress National HIV Plans for all PICTS Transition Work Plan for Nauru, Nieu, Palau and Cook Islands Transition Readiness Assessment October 2022 31 December 2022 31 December 2022 30 June 2022 Completed In-progress QUA-C- UNDP QUA-C- UNDP QUA-C- UNDP QUA-C- UNDP QUA-M- UNDP QUA-M- UNDP QUA-M- UNDP QUA-M- UNDP C19RM C19RM C19RM C19RM C19RM C19RM In-progress Plan to integrate HIV with SRHR Completed/FR Population Size Estimate for the update and revision of Performance Framework Implementation of the Capacity Development Plan (CDP) September 2022 Completed/PF update in progress In progress N/A M&E plan for Malaria N/A Completed ToRs for Malaria MTR N/A Completed Draft Report Malaria MTR 1 March 2023 Completed Reprogram savings from - Oxygen PSA Plant -Tuvalu Medical Oxygen Equipment - Kiribati Kiribati GIS project Covid PCR tests GeneXpert Equipment Covid-19 Diagn sticos and Consumables N/A N/A N/A N/A N/A N/A In progress In progress In-progress Completed Completed On-going 7
GC7 programmatic priorities
Global Fund Strategy 2023-2028 Fighting Pandemics and Building a Healthier and More Equitable World Updated Forms New Annexes Evolved Expectations Supporting country-owned programs to achieve national and global goals Available online at https://www.theglobalfund.org/en/strategy/ 9
Global Fund investments for GC7 Total GF investment in the region of $118.5M USD Focused portfolio Eligible components are HIV, TB and Malaria Application modality is tailored for focused Malaria portfolio (light) GC7 Allocation amount: Total $13,80 mil Tuberculosis HIV HIV - $6.57 mil TB - $4.77 mil Malaria - $2.46 mil 10
HIV epidemic snapshot PICs have a KP driven concentrated HIV epidemic HIV vulnerability is very high due to limited access to quality Sexual and Reproductive Health services HIV burden is low. By the end of 2021, there were an estimated 1,466 PLHIV in all the 12 PICTs. Fiji contributes 95% of the estimated number of PLHIV and 91% of those on ART in the region. ART coverage for Fiji is 46% Data source: 2022 UNAIDS GAM report (Fiji) & program data reported in 2021 MCWP PUDR 11
TB epidemic snapshot Burden of TB is heterogenous in the PICTs with a combination of high, moderate, and low TB incidence settings. Four countries namely Marshal Islands (483), Kiribati (424), Tuvalu (296) and Nauru (193) have very high TB incidence of more than 100 cases per 100,000 population In 2021, WHO estimated that there was a total of 1,652 people who fell ill with TB among all the 12 PICTs. Five countries; namely Fiji (610), Kiribati (550), Marshal Islands (200), Vanuatu (110) and Micronesia (90) had 94% of the total estimated incidence in the region Data Source: 2022 WHO Global TB reportc 12
Malaria epidemic (Vanuatu) Significant progress made over the last decade One Island (Tafea) declared malaria-free 2017 and no malaria deaths since 2011 Bold and Ambitious National Strategic Plan for Malaria Elimination 2021 - 2026 developed to achieve malaria-free status by 2026 Malaria cases were decreasing until 2022 when reported cases tripled to 1143 Annual Parasite Incidence (API) has increased from 1.3 in 2021 to 3.6 in 2022. 13 Data Source: 2022 World Malaria Report & 2022 Vanuatu NMP annual report
Priority areas for consideration Malaria TB HIV Increase ART coverage (test-and- treat) Strengthen KP community outreach Improve retention on treatment for PLHIV on ART Address inequalities, stigma & discrimination broader sexual and reproductive health (SRH) Increase access to TPT Targeted ACF for high-risk populations + contact tracing Expand capacity and utilization of WHO recommended molecular tests Decentralization of patient centered (ambulatory) DR-TB services Strengthen epidemiological and entomological surveillance Strengthen vector control (ITNs distribution and IRS) Community awareness and sensitization Quality assurance of parasitology Radical cure of P.Vivax Strengthen case reporting, investigation and response 14
Cross-cutting RSSH & PPR priorities Strengthen HMIS and disease surveillance Laboratory systems strengthening and expansion Strengthen procurement, supply and distribution of HTM drugs and commodities Address inequalities plus gender and human rights related barriers to HTM Effective community engagement and involvement in HTM program design and implementation Equitable distribution and availability of appropriately trained HRH Governance Health Information Laboratory People and communities Drugs and commodities Financing Human resources & CHWs Quality HTM Service delivery 15
Develop high-quality Funding Requests for GC7 aligned to new GF strategy by 29 May 16
Evolution of CCM to deliver on GF strategy & Governance 01 Accelerate to absorb 100% of GC6 funding by 31/12/2023 02 MCWP Portfolio Priorities 2023 Develop high-quality Funding Requests for GC7 aligned to new GF strategy 03 Develop high-quality, implementation-ready grants by 30 November 2023 04 Cross-cutting RSSH & PPR priorities 05
Countries in the Pacific Region are important implementers of Global Fund grants. Sustained commitment and successful partnerships are leading to transformative results. 18
